Keyphrases
Murine Typhus
90%
Immunogenicity
90%
PT-INR
90%
Neutralizing Antibodies
90%
Ad26
75%
CoaguChek XS
68%
Siemens
68%
COVID-19
61%
Stago
60%
Vaccine Response
60%
Thromboplastin
56%
Central Laboratory
56%
Patient Care
53%
Anticoagulation Clinic
53%
Priming Regimens
45%
Febrile Illness
45%
Coagulation Analyzer
45%
Portable Coagulometer
45%
Hemichorea
45%
Multibacillary Leprosy
45%
Malassezia Pachydermatis
45%
Fungemia
45%
SARS-CoV-2 Variants
45%
NVX-CoV2373
45%
Diabetic Ketoacidosis
45%
Varicella-zoster Virus Infection
45%
COVID-19 Risk
45%
AS03
45%
Renal Failure
45%
Kidney Transplant Recipients
45%
MRNA Vaccine
45%
Previous Infection
45%
Vaccination
45%
Pseudovirus
45%
Randomized Clinical Trial
45%
Omicron Variant
45%
H7N9 Vaccine
45%
H7N9 Influenza Virus
45%
Natural Infection
45%
Varicella Vaccine
45%
Correction Method
45%
Rapid Decline
45%
Heterologous Boost
45%
Focal Segmental Glomerulosclerosis
45%
MF59
36%
Varicella Zoster Virus
36%
Chorea
34%
COVID-19 Booster Vaccine
30%
Rickettsia Typhi
30%
Titer
30%
Medicine and Dentistry
Immunogenicity
90%
Murine Typhus
90%
Disease
79%
Focal Segmental Glomerulosclerosis
45%
Randomized Clinical Trial
45%
Influenza A (H7N9)
45%
Mifamurtide
45%
Avian Influenza
45%
Neutralizing Antibody
45%
Renal Failure
45%
Booster Dose
45%
Severe Acute Respiratory Syndrome Coronavirus 2
45%
Multibacillary Leprosy
45%
Chickenpox
45%
Malassezia
45%
Fungemia
45%
Varicella Zoster Virus
45%
Kidney Graft
45%
Diabetic Ketoacidosis
45%
Chickenpox Vaccine
34%
Influenza A Virus (H7N9)
34%
Chorea
34%
Rickettsia typhi
30%
Infection
26%
COVID-19
22%
Acute Kidney Injury
22%
Hemagglutination Inhibiting Antibody
22%
Endothelial Dysfunction
22%
Kidney Injury
22%
Uremia
22%
Rickettsiosis
22%
Acute Tubular Necrosis
22%
Vaccine Strain
22%
Patient with Type 2 Diabetes
22%
Water-Electrolyte Imbalance
22%
Varicella Zoster Vaccine
22%
Maturity Onset Diabetes of the Young
22%
Hyperglycemia
22%
Messenger RNA
22%
Bloodstream Infection
15%
Staphylococcal Bacteremia
15%
Typhus
15%
Ketoacidosis
11%
mRNA Vaccine
11%
Immunoassay
11%
Chorea Minor
11%
Vitamin B12 Deficiency
11%
Humoral Immunity
11%
Arm
11%
Antibody Response
11%
Pharmacology, Toxicology and Pharmaceutical Science
Neutralizing Antibody
100%
SARS Coronavirus
93%
Immunogenicity
90%
Messenger RNA
60%
Infection
60%
Warfarin
45%
Chickenpox
45%
Influenza A (H7N9)
45%
AS03
45%
Varicella Zoster Virus
45%
mRNA Vaccine
45%
Randomized Clinical Trial
45%
Thromboplastin
45%
Avian Influenza
45%
Diabetic Ketoacidosis
45%
Disease
37%
MF59
36%
Chorea
34%
Chickenpox Vaccine
34%
Influenza A Virus (H7N9)
27%
Normal Human
22%
Varicella Zoster Vaccine
22%
Recombinant
22%
Leporidae
22%
Metabolic Disorder
22%
Hyperglycemia
22%
Non Insulin Dependent Diabetes Mellitus
22%
Vaccine Strain
20%
Hemagglutination Inhibiting Antibody
18%
Placebo
12%
Skin Defect
11%
Immunosuppressive Agent
11%
Cyanocobalamin Deficiency
11%
Herpes Zoster
11%
Chorea Minor
11%
Aciclovir
11%
Vesicular Rash
11%
Ketoacidosis
11%
Metabolic Acidosis
11%
Hypothyroidism
11%
Immunoassay
9%
Comorbidity
9%